Home › Colorectal Cancer › California › Glendale
Colorectal Cancer clinical trials in Glendale, CA
4 studies for Colorectal Cancer are looking for participants at sites in and around Glendale (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
RecruitingPhase 3
- Los Angeles Cancer Network, Glendale
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
RecruitingPhase 3
- Los Angeles Cancer Network, Glendale
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
RecruitingPhase 1/2
- OPN Healthcare, Inc, Glendale
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
RecruitingPhase 3
- Los Angeles Cancer Network - Corporate Office, Glendale
- Los Angeles Hematology Oncology Medical Group, Glendale
- Los Angeles Hematology Oncology Medical Group, Glendale
About Colorectal Cancer
Colorectal cancer starts in the colon or rectum. It may not cause symptoms at first. Screening tests can help find it early, when treatment is most effective.
More about Colorectal Cancer on MedlinePlus
Colorectal Cancer trials in other cities
- Houston, TX102 studies
- New York City, NY78 studies
- Nashville, TN69 studies
- Boston, MA63 studies
- Los Angeles, CA59 studies
- Arlington, VA52 studies
- St. Louis, MO50 studies
- San Antonio, TX46 studies
- Philadelphia, PA44 studies
- Grand Rapids, MI40 studies
- Baldwin Park, CA37 studies
- Chicago, IL34 studies
Other studies in Glendale
- Major Depressive Disorder12 studies
- Non-Small Cell Lung Cancer9 studies
- Depression6 studies
- Cancer (all types)5 studies
- Obesity5 studies
- Breast Cancer4 studies
- Lung Cancer4 studies
- Metastatic Cancer3 studies
- Coronary Artery Disease3 studies
- Melanoma3 studies
- Macular Edema3 studies
- Overweight3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.